Selective Omission of Oncotype Dx Genomic Testing in Ultra-Low-Risk Luminal A Breast Cancer
- DOI
- 10.1016/j.clbc.2026.08.017
- Published
- 2026-10
- Container
- Clinical Breast Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clbc.2026.08.017,
title = {Selective Omission of Oncotype Dx Genomic Testing in Ultra-Low-Risk Luminal A Breast Cancer},
author = {Megha Schmalzle and Rachel Radigan and Deep Patel and Shridevi Singh and Wei Liu and Kathy Deng and Meytal Fabrikant and Manjari Pandey and Sophia Fu and Johnny Kao},
year = {2026},
journal = {Clinical Breast Cancer},
doi = {10.1016/j.clbc.2026.08.017},
url = {https://doi.org/10.1016/j.clbc.2026.08.017}
}RIS
TY - JOUR TI - Selective Omission of Oncotype Dx Genomic Testing in Ultra-Low-Risk Luminal A Breast Cancer AU - Megha Schmalzle AU - Rachel Radigan AU - Deep Patel AU - Shridevi Singh AU - Wei Liu AU - Kathy Deng AU - Meytal Fabrikant AU - Manjari Pandey AU - Sophia Fu AU - Johnny Kao PY - 2026 JO - Clinical Breast Cancer DO - 10.1016/j.clbc.2026.08.017 UR - https://doi.org/10.1016/j.clbc.2026.08.017 ER -
APA
Schmalzle, M., Radigan, R., Patel, D., Singh, S., Liu, W., Deng, K., Fabrikant, M., Pandey, M., Fu, S., & Kao, J. (2026). Selective Omission of Oncotype Dx Genomic Testing in Ultra-Low-Risk Luminal A Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.08.017
Source records
- crossref · retrieved 2026-09-26T06:48:06.406Z